RheumaGen

0 followers


RheumaGen is a gene-editing technology developing therapeutics to cure rheumatoid arthritis. It offers an HLA gene-editing platform that uses stem-cell-enriched blood to alter DNA to suppress the immune system and stop rheumatoid arthritis's abnormal immune response.

Industries

Headquarters

Employees

Links

Org chart

Richard Freed
Chief Executive Officer

Richard Freed

Collapse
Brian Hart
Co-Founder & Chief Operating Officer
Ryan H.
Chief Legal Officer
Tate Hermanson
VP of Finance